Skip to main content
Treatment for oral bacteria reduces Alzheimer's disease marker
7/19/2019

An investigative treatment for Porphyromonas gingivalis bacteria, which cause gum disease, was associated with reductions in blood markers of inflammation as well as ApoE protein fragments in the spinal fluid of people with mild to moderate Alzheimer's disease, according to a small trial presented at the Alzheimer's Association annual meeting. A larger clinical trial is underway, and a vaccine for the bacterium is also being developed.

Full Story: